USCG issues its 34th BWMS type approval

FierceBiotechTakeda pivotal trial win improves convenience for PID patients relative to HyQvia

Endpoints NewsCelcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series A

FierceBiotechWindward catches $165M breeze to fuel long-acting TSLP ambitions

Endpoints NewsBiotech has a new startup model: Small team, big check and Chinese assets

Thermo FisherThermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor - Contract Pharma

PharmaVoiceProtein degraders gain speed as Arvinas scores landmark approval

Endpoints NewsWindward Bio gets $165M to take China-derived drug into Phase 3 asthma trial

BioWorldBeijing Danatlas Pharmaceutical Technology prepares new PARG inhibitors

BioWorldShanghai Pharmaceuticals reports new FR-α-targeting ADCs

BioWorldSanyou Biopharmaceuticals discloses TROP2-targeting ADCs

BioWorldHoliday notice

BioWorldBeone eyes Huahui Health’s trispecific HH-160 with $2B option deal